2018 International Congress » Parkinson's Disease: Pathophysiology

Date: Monday, October 8, 2018

Time: 1:15pm-2:45pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:15pm-2:45pm: A metabolomic signature of treated and drug-naïve patients with Parkinson disease: A pilot study

J. Troisi, A. Landolfi, C. Vitale, K. Longo, A. Cozzolino, M. Squillante, M.C. Savanelli, P. Barone, M. AmbonI (Salerno, Italy)

1:15pm-2:45pm: A patient with myotonic dystrophy type 1 and parkinsonism

J. Choi, J. Lee, H. Kim, B. Jeon (Seoul, Republic of Korea)

1:15pm-2:45pm: A post-mortem and in vivo study of neuroinflammation and Toll like-receptors in Parkinson’s disease

A. Kouli, W.L. Kuan, K. Scott, X. He, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

1:15pm-2:45pm: Activation of chaperone-mediated autophagy reduces oligomeric alpha-synuclein accumulation in LRRK2(R1441G) knockin mouse model of Parkinson’s disease (PD)

P.W.L. Ho, C.S.C. Lam, M.C.T. Leung, S.Y.Y. Pang, H.F. Liu, L. Li, M.H.W. Kung, D. Ramsden, SL. Ho (Hong Kong)

1:15pm-2:45pm: Alpha-synuclein oligomer and rotenone treatments injury the dopaminergic neuron via inhibiting the expression of gene SEMA6D

X. Yingyu (Guangzhou, China)

1:15pm-2:45pm: Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease

Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)

1:15pm-2:45pm: Antibodies to alpha-Synuclein in Parkinson disease

D. Labunskiy (Santa Rosa, CA, USA)

1:15pm-2:45pm: Apathy in Parkinson’s disease is associated with abnormal alpha oscillatory behaviour during incentivized movement

M. Zhu, S. Garg, A. HajiHosseini, S. Appel-Cresswell, M. McKeown (Vancouver, BC, Canada)

1:15pm-2:45pm: Assessment of clinical peculiarities of violations of vertical vision in patients with Parkinson’s disease

M. Salokhiddinov, D. Akramova (Tashkent city, Uzbekistan)

1:15pm-2:45pm: Association between serum Vitamin D levels and Parkinson’s disease: A systematic review and meta-analysis

XY. Luo, R. Ou, HF. Shang (Chengdu, China)

1:15pm-2:45pm: Automated immunohistochemical detection of pathological alpha-synuclein in human tissue biopsy

TS. Tsao, A. Racolta, H. Zhang, M. Robida, J. Pugh, T. Beach, T. Kremer, C. Czech, K. Taylor, W. Zago, L. Pestic-Dragovich, L. Tang, S. Dziadek (Tucson, AZ, USA)

1:15pm-2:45pm: B lymphocytes may be protective in early Parkinson’s disease and in an animal model of dopaminergic cell death

K. Scott, C. Williams-Gray, R. Wijeyekoon, S. Hayat, K. Hall, P. Tyers, R. Mathews, R. Barker, M. Clatworthy (Cambridge, United Kingdom)

1:15pm-2:45pm: Bidirectional gut-to-brain and brain-to-gut propagation of α-synuclein pathology in non-human primates

ML. Arotçarena, S. Dovero, A. Prigent, M. Bourdenx, P. Aubert, I. Trigo, G. Porras, ML. Thiolat, M. Tasselli, C. Estrada, A. Recasens, J. Blesa, M. Herrero, N. Carillo, M. Vila, J. Obeso, P. Derkinderen, B. Dehay, E. Bezard (Bordeaux, France)

1:15pm-2:45pm: Bmal1 deficiency aggravates MPTP-induced dopaminergic cell death through promoting neuroinflammation

C. Gu, W. Liu, X. Gu, F. Wang, Y. Yang, C. Liu (Su Zhou, China)

1:15pm-2:45pm: Bone health and laboratorial correlations of Vitamin D in Parkinson’s disease

L. Leandro, C. Moreira, H. Teive (Curitiba, Brazil)

1:15pm-2:45pm: Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

M. Bhargava, S. Bhargava (Kanpur, India)

1:15pm-2:45pm: Catecholamines interrelation in plasma of early diagnosed treatment-naive patients with Parkinson disease

D. Khasanova, Z. Zalyalova, M. Ugrumov (Kazan, Russian Federation)

1:15pm-2:45pm: Cell and animal models lacking RAB39B show biochemical and behavioural phenotypes that model aspects of Parkinson’s disease

Y. Gao, G. Wilson, S. Stephenson, K. Bozaoglu, M. Dottori, P. Thomas, P. Lockhart (Melbourne, Australia)

1:15pm-2:45pm: Characterization of the preclinical model parkinQ311X

A. Ciammola, M. Regoni, D. Mercatelli, L. Croci, G. Serratto, S. Fasano, L. Murru, S. Novello, M. Pingue, V. Silani, G. Consalez, F. Valtorta, M. Passafaro, M. Morari, J. Sassone (Milan, Italy)

1:15pm-2:45pm: Classification of Dopaminergic-State and Motor Activity by Theta, Beta and Gamma Activity in Parkinson’s Disease

I. Weber, C. Oehrn, N. Apetz, T. Dembek, F. Jung, E. Florin, L. Timmermann (Marburg, Germany)

1:15pm-2:45pm: Clinical correlates of stuttering in advanced Parkinson’s disease

T. Tsuboi, H. Watanabe, Y. Tanaka, R. Ohdake, M. Hattori, K. Kawabata, K. Hara, D. Nakatsubo, S. Maesawa, Y. Kajita, T. Wakabayashi, M. Katsuno, G. Sobue (Nagoya, Japan)

1:15pm-2:45pm: Cortical correlates of dual-task turning with and without freezing of gait

M. Mancini, S. Stuart (Portland, OR, USA)

1:15pm-2:45pm: Decreased amyloid-beta in patients with Idiopathic Parkinson’s Disease and white matter hyperintensities

I. Markaki, S. Klironomos, P. Svenningsson (Stockholm, Sweden)

1:15pm-2:45pm: Deletion of GBA2 in neuronopathic Gaucher’s disease medaka can’t rescue the phenotype

E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

1:15pm-2:45pm: Determination of falling direction in Parkinson’s disease patients using a wearable sensor

Y. Okuma, H. Mitoma (Izunokuni, Japan)

1:15pm-2:45pm: Dietary habits, motor and cognitive impairment in Parkinson’s Disease

A. Pilotto, MC. Rizzetti, m. Oppini, C. passeri, A. Alberici, R. Turrone, M. Cosseddu, D. Placidi, M. Turla, b. Borroni, R. Lucchini, A. Padovani (Brescia, Italy)

1:15pm-2:45pm: Direction of Turning in Parkinson’s Disease: More Affected Side or Less Affected Side?

S.M. Cheon, J.W. Kim (Busan, Republic of Korea)

1:15pm-2:45pm: Distinct Blood Leukocytes Expression Profiles of Long Non-coding RNAs and mRNAs in Parkinson’s disease patients

Y. Fan, Z. Xue (Wuhan, China)

1:15pm-2:45pm: Effects of Glial Heme Oxygenase-1 on Neuronal Alpha-Synuclein in the GFAP.HMOX1 Mouse Model of Parkinson’s Disease

M. Cressatti, W. Song, A. Turk, C. Galindez, H. Schipper (Montreal, QC, Canada)

1:15pm-2:45pm: Effects of neural stem cell transplantation on the differentiation of dopaminergic neurons in the substantia nigra and changes to rotational behavior of Parkinson’s disease rats

J.J. Xiao, X.P. Wang (Shanghai, China)

1:15pm-2:45pm: Enhancing protein palmitoylation is protective in alpha-synuclein dependent cytotoxicity

G. Ho, T. Imberdis, S. Nuber, U. Dettmer, D. Selkoe (Boston, MA, USA)

1:15pm-2:45pm: Examination of paravertebral muscular force in camptocormia

R. Wolke, N. Margraf, J. Kuhtz-Buschbeck, G. Deuschl (Kiel, Germany)

1:15pm-2:45pm: Experimental rotenone model

X. Djakhangir, A. Ziyoda (Tashkent, Uzbekistan)

1:15pm-2:45pm: Freezing of Gait in Parkinson’s Disease: Clinico-biochemical Observations

B. Mondal, R. Banerjee, K. Chatterjee, A. Roy, S. Shubham, P. Basu, S. Choudhury, H. Kumar (Kolkata, India)

1:15pm-2:45pm: Freezing of gait recognition in Parkinson’s disease: A subject independent objective method

V. Rama Raju (Hyderabad, India)

1:15pm-2:45pm: Frontal-subcortical cognitive impairments in Parkinson’s patients with freezing of gait

J. Garcia-Caldentey, MA. Prats-Sedano, E. Estelrich-Peyret, PJ. Garcia-Ruiz (Palma de Mallorca, Spain)

1:15pm-2:45pm: GBA haploinsufficiency accelerated alpha synuclein pathology with altered lipid metabolism in a premotor model of Parkinson’s disease

H. Yamakado, M. Ikuno, H. Akiyama, L. Parajuli, K. Taguchi, J. Hara, N. Uemura, Y. Hatanaka, K. Higaki, M. Tanaka, M. Koike, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

1:15pm-2:45pm: Identification of putative serum biomarkers for parkin-related Parkinson’s disease by metabolome analysis

T. Ogawa, T. Hatano, A. Okuzumi, S. Ueno, A. Mori, Y. Oji, M. Fujimaki, T. Koinuma, S. Saiki, N. Hattori (Tokyo, Japan)

1:15pm-2:45pm: Influence of dopamine deficiency on interhemispheric crosstalk in Parkinson’s disease

P. Loehrer, F. Nettersheim, I. Weber, F. Jung, L. Timmermann (Marburg, Germany)

1:15pm-2:45pm: Insulin degrading enzyme, a novel key protein against alpha-synuclein oligomers formation?

I. Martinez-Valbuena, R. Valenti-Azcarate, I. Amat-Villegas, I. Marcilla-Garcia, L. Alonso-Herrero, M. Carmona-Abellan, G. Marti-Andres, MT. Tuñon-Alvarez, MR. Luquin-Piudo (Pamplona, Spain)

1:15pm-2:45pm: Interaction of TDP-43 with IAPP in pancreatic beta cells of patients with sinucleinopathies

R. Valenti-Azcarate, I. Martinez-Valbuena, C. Arean-Cuns, I. Marcilla-García, L. Alonso-Herrero, M. Carmona-Abellan, G. Marti-Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

1:15pm-2:45pm: Investigating the role of microRNA biogenesis pathway in neuroprotection in primary neuronal culture model of Parkinson’s disease

J. Konovalova, S. Er, S. Soleimanbeigi, P. Chmielarz, A. Domanskyi (Helsinki, Finland)

1:15pm-2:45pm: Levodopa-induced dyskinesia in Parkinson’s disease: Sleep matters

N. Amato, M. Manconi, J.C. Möller, S. Sarasso, P. Stanzione, C. Städler, A. Kaelin-Lang, S. Galati (Lugano, Switzerland)

1:15pm-2:45pm: Low body weight is associated with poor functional status in Parkinson’s disease (PD)

HF. Chan, N. Cheung, D. Chau, CW. Woo, B. Chee, A. Leung, S. Or, WC. Fong (Hong Kong)

1:15pm-2:45pm: Microbiota DNA in the blood of patients with Parkinson’s disease

S.Q. Xu, Y.W. Qian, X.D. Yang, S.D. Chen, Q. Xiao (Shanghai, China)

1:15pm-2:45pm: Microglial activation, white matter and hippocampal damage correlate with cognitive impairment in chronic cerebral hypoperfused and MPTP-lesioned mice

Y. Gao, H. Tang, K. Nie, R. Zhu, L. Gao, S. Feng, L. Wang, J. Zhao, Z. Huang, Y. Zhang, L. Wang (Guangzhou, China)

1:15pm-2:45pm: Modulation of CaMKIIa-NR2B interaction in levodopa-induced dyskinesia in 6-OHDA- lesioned Parkinson’s rats

XS. Wang, WW. Wang, CL. Xie (Wenzhou, China)

1:15pm-2:45pm: Molecular Genetics and Functional Studies of LRRK2 Gene Variations in Parkinson’s Disease

M-L. Chen, R-M. Wu (Taipei, Taiwan)

1:15pm-2:45pm: Motivational effects on action selection and memory

S. Hirschbichler, J. Ibáñez, L. Rocchi, R. Greenwood, J. Rothwell, S. Manohar (London, United Kingdom)

1:15pm-2:45pm: Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Cerebrospinal Fluid C-Reactive Protein

H. Sanjari Moghaddam, M.H. Aarabi (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: Multisite Tissue and Biofluid Sampling for Alpha-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)

L. Chahine, T. Beach, C. Coffey, C. Caspell-Garcia, C. Alder, G. Serrano, S. Mosovsky, T. Foroud, C. Linder, H. Riss, D. Ecklund, J. Seibyl, A. Mallya, V. Arnedo, L. Riley, K. Dave, D. Jennings, B. Mollenhauer (Pittsburgh, PA, USA)

1:15pm-2:45pm: Nanoscale imaging reveals disorganization of the brain extracellular space in Lewy body-injected mice

F. Soria, N. Danne, C. Paviolo, E. Doudnikoff, B. Dehay, L. Groc, L. Cognet, E. Bezard (Bordeaux, France)

1:15pm-2:45pm: Natural occurring antibodies reduce aggregation of α-synuclein

A. Braczynski, E. Agerschou, Y. Kronimus, W. Hoyer, R. Dodel, B. Falkenburger, J. Schulz, J. Bach (Aachen, Germany)

1:15pm-2:45pm: Neurophysiological correlates of bradykinesia in Parkinson’s disease

M. Bologna, A. Guerra, G. Paparella, L. Giordo, D. Alunni Fegatelli, AR. Vestri, J. Rothwell, A. Berardelli (Rome, Italy)

1:15pm-2:45pm: Neuroprotection effects of probiotics strains on a chronic MPTP-induced mouse model of Parkinson’s disease

Y. Qian, X. Yang, S. Xu, Q. Xiao (Shanghai, China)

1:15pm-2:45pm: Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and Parkinson’s Disease: Preliminary report

B. Lisewska, P. Lisewski, P. Szarwas, N. Piekuś-Słomka, D. Rość (Bydgoszcz, Poland)

1:15pm-2:45pm: New evidence for thalamic dysfunction in Parkinsonian rats

L. Grandi, G. Di Giovanni, E. Fedele, G. Orban, A. Salvadè, W. Song, A. Stefani, A. Kaelin-Lang, S. Galati (Taverne, Switzerland)

1:15pm-2:45pm: No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

F. Hopfner, S. Müller, D. Steppat, J. Miller, N. Schmidt, K.P. Wandinger, F. Leypoldt, D. Berg, A. Franke, W. Lieb, L. Tittmann, M. Balzer-Geldsetzer, S. Baudrexel, R. Dodel, R. Hilker-Roggendorf, E. Kalbe, J. Kassubek, T. Klockgether, I. Liepelt-Scarfone, B. Mollenhauer, P. Neuser, K. Reetz, O. Riedel, C. Schulte, J. Schulz, A. Spottke, A. Storch, C. Trenkwalder, G. Deuschl, G. Kuhlenbäumer (Kiel, Germany)

1:15pm-2:45pm: No MPTP-induced behavioral deficits or Striatal field potential alterations in crossbreds of MPTP-susceptible and MPTP-resistant mice strains

P. Alladi, D. Vidyadhara, S. Arun, B. Kutty (Bengaluru, India)

1:15pm-2:45pm: Partial depletion of peripheral M1 macrophages ameliorates the neuroinflammation and dopaminergic neuronal death in the brain of a MPTP-induced mouse model of PD

A. Yan, Y. Zhang, J. Lin, L. Song, X. Wang, Z. Liu (Shanghai, China)

1:15pm-2:45pm: Peripheral Inflammatory Mediators in Parkinson’s Disease – A Potential Biomarker

K. Chatterjee, A. Roy, R. Banerjee, S. Halder, S. Choudhury, P. Basu, S. Shubham, H. Kumar (Kolkata, India)

1:15pm-2:45pm: Pharmacological modulation of lysosomal glucocerebrosidase activity in the Thy1-aSYN mouse model of Parkinson’s disease

K. Belarbi, E. Cuvelier, H. Carrie, M.A. Bonte, W. Sibran, C. Leghay, J. Von Gerichten, V. Nordström, R. Sandhoff, T. Comptdaer, N. Jouy, E. Mutez, A. Destee, C. Pincon, B. Gressier, M.C. Chartier-Harlin (Lille, France)

1:15pm-2:45pm: Predictors of freezing of gait in newly diagnosed Parkinson’s disease: Clinical, dopamine transporter imaging and CSF markers in the PPMI cohort

R. Kim, J. Lee, H.J. Kim, A. Kim, B. Jeon, U.J. Kang, S. Fahn (Seoul, Republic of Korea)

1:15pm-2:45pm: Prefrontal cortical stimulation to treat anxiety and depression in Parkinson’s disease

C. de Hemptinne, W. Chen, C. Racine, A. Seritan, A. Miller, J. Mergenthaler, S. Rajagopalan, J. Ostrem, M. San Luciano, P. Starr (San Francisco, CA, USA)

1:15pm-2:45pm: Presence of Lewy dots in the brain of patients with Creutzfeldt-Jakob disease

R. Valenti-Azcarate, I. Martinez-Valbuena, M. Tuñon-Alvarez, I. Marcilla-Garcia, L. Alonso-Herrero, M. Carmona-Abellan, G. Marti-Andres, E. Erro-Aguirre, M. Luquin-Piudo (Pamplona, Spain)

1:15pm-2:45pm: Prevalence and risk factor of peak-dose dyskinesia in Thai patients with Parkinson’s disease

S. Klanbut, C. Luangsinsiri, N. Piyaparneekul, C. Khongbut, K. Methawasin (Nakhon Nayok, Thailand)

1:15pm-2:45pm: Profiles of microRNA in cerebrospinal fluid could be potential biomarkers for identifying motor subtype of Parkinson’s disease

W. Jang (Gangneung, Republic of Korea)

1:15pm-2:45pm: Properties of oscillatory neuronal activity in the basal ganglia and thalamus in patients with Parkinson’s disease

P. Zhuang, M. Hallett, G. Du, Y. Zhang, Y. Li (Beijing, China)

1:15pm-2:45pm: Protective effects of Mucuna pruriens seed on rat brain: A therapeutic potential drug for Parkinson’s disease

S. Rajput, S. Sinha (New Delhi, India)

1:15pm-2:45pm: PrP as a receptor of alpha-synuclein in the pancreas of patients with synucleinopathies

I. Martinez-Valbuena (Pamplona, Spain)

1:15pm-2:45pm: Pupil evaluation as the test for the clinical manifestations of Parkinson’s disease

T. Araga, M. Shiraishi, K. Shinohara, Y. Hasegawa (Kawasaki, Japan)

1:15pm-2:45pm: Quantitative Keyboard Tapping Measurement Correlates with Electrophysiological Changes in STN LFPs of PD Patients Treated with L-dopa Better Than UPDRS Subscores

M. Ozturk, A. Abosch, D. Francis, J. Wu, N. Ince (Houston, TX, USA)

1:15pm-2:45pm: Red cell distribution with levels in Parkinson’s disease patients

G. Ozgen Kenangil, B.C. Ari, F. Altuntas Kaya, M. Demir, F. Mayda Domac (Istanbul, Turkey)

1:15pm-2:45pm: Reduced vesicular storage of catacholamines enhance MPTP-induced death of dopaminergic neurons in locus coeruleus and olfactory bulb

K. Ma, J. Huang, L. Liu, X. Fang, Y. Xia, F. Wan, S. Yin, L. Kou, N. Xiong, T. Wang (Wuhan, China)

1:15pm-2:45pm: Relationship of Vitamin D deficiency with Parkinson’s disease risk

M. Sanoeva, N. Mansurova (Bukhara, Uzbekistan)

1:15pm-2:45pm: Risk estimation in the years preceding diagnosis of Parkinson’s disease in the PREDICT-PD cohort

S. Auger, D. Rack, J. Bestwick, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

1:15pm-2:45pm: Role of microglia in the transmission of α-syn-containing exosomes

Y. Xia, G. Zhang, J. Huang, N. Xiong, K. Ma, X. Guo, F. Wan, L. Kou, S. Yin, T. Wang (Wuhan, China)

1:15pm-2:45pm: Saccades in Parkinson’s disease: Hypometric, slow, or maladaptive?

L. Neilson, F. Ghasia, A. Shaikh (Cleveland, OH, USA)

1:15pm-2:45pm: Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson’s disease?

C. Aerts, C. Hirtz, V. Gonzalez, L. Collombier, M. De Verdal, C. Geny, M. Charif, E. Moulis, P. Fabbro-Peray, D. Deville Periere, P. Lapeyrie, G. Castelnovo, S. Lehmann (Nimes, France)

1:15pm-2:45pm: Salivary Alpha-Synuclein and tau in Parkinson’s Disease and Progressive Supranuclear Palsy

G. Vivacqua, A. Fabbrini, R. Mancinelli, D. Belvisi, G. Fabbrini, A. Suppa, A. Berardelli (Cambridge, United Kingdom)

1:15pm-2:45pm: Serum glutamate is associated with the motor subtype of Parkinson’s disease

A. Latypova, I. Mironova, O. Izhboldina, I. Zhukova, N. Zhukova, E. Kolupaeva (Tomsk, Russian Federation)

1:15pm-2:45pm: Serum Leptin levels in Iranian patients with Parkinson’s disease

M. Salari, M. Etemadifar, M. Barzegar (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: Soluble TREM2 and Central and Peripheral Inflammatory Biomarkers in Parkinson’s Disease

L. Bekris, M. Khrestian, Y. Shao, H. Fernandez, J. Leverenz (Cleveland, OH, USA)

1:15pm-2:45pm: Spatiotemporal patterns of direct and indirect pathway striatal projection neurons in mouse model of Parkinson’s disease and dyskinesia

C. Alcacer, M. Mendonca, A. Klaus, MA. Cenci, R. Costa (Lisbon, Portugal)

1:15pm-2:45pm: Speech intelligibility and comprehensibility in Slovak patients with Parkinson’s disease

A. Kušnírová, Ľ. Mičianová, Z. Košutzká, I. Straka, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

1:15pm-2:45pm: Status of riding bicycle and reasons for cessation of cycling in patients with Parkinson disease: A Japanese single center cross-sectional survey

K. Takahashi, K. Ota, K. Seo, H. Kawasaki, K. Ikeda, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Tamura, N. Araki, T. Yamamoto (Saitama-ken, Japan)

1:15pm-2:45pm: STN DBS – A study of frequency of gait (fog) in Parkinson’s disease

V. Rama Raju, R. Borgohain (Hyderabad, India)

1:15pm-2:45pm: Substantia nigra hyperechogenicity is similarly enlarged in Gaucher and in GBA mutation carriers

D. Arkadir, A. Zimran (Jerusalem, Israel)

1:15pm-2:45pm: T lymphocytes in Parkinson’s disease pathogenesis and therapy: A systematic review

J. Baird, J. Quinn (Portland, OR, USA)

1:15pm-2:45pm: Tau and α-synuclein autoantibodies as potential biomarkers for Parkinson’s and Alzheimer’s diseases

A. Shalash, M. Salama, M. Makar, T. Roushdy, M. El-Balkimy (Cairo, Egypt)

1:15pm-2:45pm: Tetrahydroisoquinoline Molecule Identified in Traditional Ayurveda Medicine Modulates Inflammation in MPTP Mice

R. Banerjee, R. Paidi, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

1:15pm-2:45pm: The Association between Infections and Parkinson Disease: A Systematic Review and Meta-analysis

M. Morra, S. Ghozy, E. Sakr, M. Elfaituri, M. Khattab, M. Mahmoud, S. Mehyar, M. Alhattab, A. Ahmed Ismail, M. Abdelmongy, M. Fahmy, E. Gharib, A. Hallab, N. Huy (Cairo, Egypt)

1:15pm-2:45pm: The difference in posture reaction against backward perturbation between patients with Parkinson’s disease and healthy controls

K. Kannari, S. Koseki, C. Narita, S. Sugo. (Aomori, Japan)

1:15pm-2:45pm: The increased α-syn expression inhibits exosomal secretion

Y. Ishiguro, T. Tsunemi, A. Yoroizaka, W. Akamatsu, N. Hattori (Tokyo, Japan)

1:15pm-2:45pm: The Prevalence of Tandem Gait Abnormality in Parkinson’s Disease

J. Margolesky, S. Bette, D. Shpiner, T. Rundek, C. Luca, H. Moore, C. Singer (Miami, FL, USA)

1:15pm-2:45pm: Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism

R. Cilia, M. Barichella, M. Severgnini, E. Cassani, C. Bolliri, S. Caronni, V. Ferri, R. Cancello, S. Faierman, G. Pinelli, C. Ceccarani, G. De Bellis, L. Zecca, E. Cereda, C. Consolandi, G. Pezzoli (Milan, Italy)

1:15pm-2:45pm: Unveiling the function of altered gut microbiota composition in Parkinson’s disease

A.H. Tan, C.W. Chong, C.S.J. Teh, I.K.S. Yap, M.F. Loke, J. Bowman, S.L. Song, J.Y. Tan, B.H. Ang, Y.Q. Tan, H.S. Yong, A.E. Lang, S. Mahadeva, S.Y. Lim (Kuala Lumpur, Malaysia)

1:15pm-2:45pm: Validation of protein phosphatases that regulate the LRRK2 phosphorylation cycle

M. Drouyer, M. Emanuele, R. Lefebvre, K. Cailliau-Maggio, A. martoriati, T. Comptdaer, P. Semaille, E. Mutez, W. Sibran, N. Wolkoff, E. Lobbestael, M. Bolliger, V. Baekelandt, J. Nichols, MC. Chartier-Harlin, JM. Taymans (Lille, France)

1:15pm-2:45pm: Variable selection using machine-learning to identify new signatures of patient-derived aggregated α-synuclein-induced neurodegeneration in non-human primates

M. Bourdenx, A. Nioche, S. Dovero, M.L. Arotçarena, S. Camus, G. Porras, M.L. Thiolat, N. Rougier, A. Prigent, P. Aubert, S. Bohic, N. Kruse, B. Mollenhauer, S. Novello, M. Morari, I. Trigo, M. Goillandeau, M. Tasselli, C. Perier, N. Garcia Carrillo, C. Estrada, A. Recasens, J. Blesa, M. Herrero, P. Derkinderen, M. Vila, J. Obeso, B. Dehay, E. Bezard (Bordeaux, France)

1:15pm-2:45pm: Vascular risk factors prevalence differences between Vascular Parkinsonism (VaP) and Parkinson Disease (PD) in a hospital cross-section study

A. Velon, M. Mendes, R. Raimundo, R. Jesus, R. Almendra (Vila Real, Portugal)

1:15pm-2:45pm: α-synuclein aggregation and propagation in marmoset brains deteriorates its motor function

T. Yabumoto, K. Baba, H. Hayakawa, K. Ikenaka, F. Yoshida, T. Uehara, R. Nakatani, H. Tsuda, S. Nagano, H. Hamanaka, Y. Nagai, M. Hirata, H. Mochizuki. (Osaka, Japan)

1:15pm-2:45pm: α-synuclein antibody 5G4 identifies manifest and prodromal Parkinson’s disease in colonic mucosa

M. Skorvanek, E. Gelpi, E. Mechirova, Z. Ladomirjakova, V. Han, N. Lesko, E. Feketeova, J. Ribeiro Ventosa, F. Kudela, K. Kulcsarova, S. Babinska, S. Toth, L. Gombosova, F. Trebuna, M. Lutz, Z. Gdovinova, G. Kovacs (Kosice, Slovakia)

« View all sessions from the 2018 International Congress.